Severe clinical phenotypes of heterozygous females with X-linked chronic granulomatous disease

Affiliations

¹ Division of Allergy and Immunology, Department of Pediatrics, Duke University, Durham, NC. Electronic address: niraj.patel@duke.edu.
² Division of Allergy and Immunology, Johns Hopkins University, Baltimore, Md.
³ Division of Pediatric Pulmonology, Allergy, and Immunology, Medical University of South Carolina, Charleston, SC.
⁴ Division of Pediatric Allergy, Immunology, and Rheumatology, University Hospitals Rainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, Ohio.
⁵ Neutrophil and Immunological Monitoring Labs, Frederick National Laboratory for Cancer Research, Frederick, Md.
⁶ Division of Allergy and Immunology, Duke University, Durham, NC.
⁷ Division of Allergy and Immunology, University of South Florida, Tampa, Fla.
⁸ Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
⁹ Division of Pediatric Allergy and Immunology, University of Pittsburgh Medical Center, Pittsburgh, Pa.
¹⁰ Division of Allergy and Immunology, Johns Hopkins University, Baltimore, Md; Institute for Clinical and Translational Research and Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St Petersburg, Fla. Electronic address: jleidin1@jhmi.edu.

Niraj C Patel et al. J Allergy Clin Immunol Pract. 2024 Dec.

. 2024 Dec;12(12):3452-3456.e1.

doi: 10.1016/j.jaip.2024.09.018. Epub 2024 Sep 25.

¹ Division of Allergy and Immunology, Department of Pediatrics, Duke University, Durham, NC. Electronic address: niraj.patel@duke.edu.
² Division of Allergy and Immunology, Johns Hopkins University, Baltimore, Md.
³ Division of Pediatric Pulmonology, Allergy, and Immunology, Medical University of South Carolina, Charleston, SC.
⁴ Division of Pediatric Allergy, Immunology, and Rheumatology, University Hospitals Rainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, Ohio.
⁵ Neutrophil and Immunological Monitoring Labs, Frederick National Laboratory for Cancer Research, Frederick, Md.
⁶ Division of Allergy and Immunology, Duke University, Durham, NC.
⁷ Division of Allergy and Immunology, University of South Florida, Tampa, Fla.
⁸ Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
⁹ Division of Pediatric Allergy and Immunology, University of Pittsburgh Medical Center, Pittsburgh, Pa.
¹⁰ Division of Allergy and Immunology, Johns Hopkins University, Baltimore, Md; Institute for Clinical and Translational Research and Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St Petersburg, Fla. Electronic address: jleidin1@jhmi.edu.

No abstract available

References

1. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000;79:170–200. - PubMed
1. Marciano BE, Zerbe CS, Falcone EL, Ding L, DeRavin SS, Daub J, et al. X-linked carriers of chronic granulomatous disease: illness, lyonization, and stability. J Allergy Clin Immunol 2018;141:365–71. - PubMed
1. Leiding JW, Holland SM. Chronic granulomatous disease. In: Adam, Feldman, Mirzaa, Pagon, Wallace, Bean, et al., editors. GeneReviews®. Seattle; 1993. - PubMed
1. Arnold DE, Heimall JR. A review of chronic granulomatous disease. Adv Ther 2017;34:2543–57. - PMC - PubMed
1. Leiding JW, Arnold DE, Parikh SH, Logan BR, Marsh RA, Griffith LM, et al. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. Blood 2023;142:2105–18. - PMC - PubMed